{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T13:54:59Z","timestamp":1782741299345,"version":"3.54.5"},"reference-count":126,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2013,7,11]],"date-time":"2013-07-11T00:00:00Z","timestamp":1373500800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Drugs Aging"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1007\/s40266-013-0099-3","type":"journal-article","created":{"date-parts":[[2013,7,10]],"date-time":"2013-07-10T10:11:47Z","timestamp":1373451107000},"page":"755-764","source":"Crossref","is-referenced-by-count":46,"title":["BACE1 as a Therapeutic Target in Alzheimer\u2019s Disease: Rationale and Current Status"],"prefix":"10.1007","volume":"30","author":[{"given":"Genevieve","family":"Evin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Hince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,7,11]]},"reference":[{"key":"99_CR1","doi-asserted-by":"crossref","unstructured":"Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E. Alzheimer's disease. Lancet. 2011;377(9770):1019\u201331.","DOI":"10.1016\/S0140-6736(10)61349-9"},{"key":"99_CR2","volume-title":"Dementia: a public health priority","author":"World Health Organization and Alzheimer\u2019s Disease International","year":"2012","unstructured":"World Health Organization and Alzheimer\u2019s Disease International. Dementia: a public health priority. Geneva: World Health Organization; 2012."},{"issue":"Pt 11","key":"99_CR3","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1093\/brain\/awl251","volume":"129","author":"CL Masters","year":"2006","unstructured":"Masters CL, Beyreuther K. Alzheimer\u2019s centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway. Brain. 2006;129(Pt 11):2823\u201339.","journal-title":"Brain"},{"issue":"12","key":"99_CR4","doi-asserted-by":"crossref","first-page":"4245","DOI":"10.1073\/pnas.82.12.4245","volume":"82","author":"CL Masters","year":"1985","unstructured":"Masters CL, Simms G, Weinman NA, Multhaup G, McDonald BL, Beyreuther K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci USA. 1985;82(12):4245\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5054","key":"99_CR5","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","volume":"256","author":"JA Hardy","year":"1992","unstructured":"Hardy JA, Higgins GA. Alzheimer\u2019s disease: the amyloid cascade hypothesis. Science. 1992;256(5054):184\u20135.","journal-title":"Science"},{"issue":"5580","key":"99_CR6","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1126\/science.1072994","volume":"297","author":"J Hardy","year":"2002","unstructured":"Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer\u2019s disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353\u20136.","journal-title":"Science"},{"key":"99_CR7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.neuro.26.043002.094919","volume":"26","author":"R Mayeux","year":"2003","unstructured":"Mayeux R. Epidemiology of neurodegeneration. Annu Rev Neurosci. 2003;26:81\u2013104.","journal-title":"Annu Rev Neurosci"},{"issue":"6","key":"99_CR8","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0197-4580(02)00042-8","volume":"23","author":"J Hardy","year":"2002","unstructured":"Hardy J. Testing times for the \u201camyloid cascade hypothesis\u201d. Neurobiol Aging. 2002;23(6):1073\u20134.","journal-title":"Neurobiol Aging"},{"issue":"9","key":"99_CR9","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","volume":"10","author":"E Karran","year":"2011","unstructured":"Karran E, Mercken M, De Strooper B. The amyloid cascade hypothesis for Alzheimer\u2019s disease: an appraisal for the development of therapeutics. Nat Rev Drug Discov. 2011;10(9):698\u2013712.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"99_CR10","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.biocel.2007.07.013","volume":"40","author":"PJ Crouch","year":"2008","unstructured":"Crouch PJ, Harding SM, White AR, Camakaris J, Bush AI, Masters CL. Mechanisms of a beta mediated neurodegeneration in Alzheimer\u2019s disease. Int J Biochem Cell Biol. 2008;40(2):181\u201398.","journal-title":"Int J Biochem Cell Biol"},{"key":"99_CR11","doi-asserted-by":"crossref","first-page":"630865","DOI":"10.4061\/2011\/630865","volume":"2011","author":"RA Armstrong","year":"2011","unstructured":"Armstrong RA. The pathogenesis of Alzheimer\u2019s disease: a reevaluation of the \u201camyloid cascade hypothesis\u201d. Int J Alzheimers Dis. 2011;2011:630865.","journal-title":"Int J Alzheimers Dis"},{"issue":"3","key":"99_CR12","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1124\/jpet.106.114009","volume":"321","author":"HG Lee","year":"2007","unstructured":"Lee HG, Zhu X, Castellani RJ, Nunomura A, Perry G, Smith MA. Amyloid-beta in Alzheimer disease: the null versus the alternate hypotheses. J Pharmacol Exp Ther. 2007;321(3):823\u20139.","journal-title":"J Pharmacol Exp Ther"},{"issue":"Suppl 1","key":"99_CR13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1471-4159.2011.07575.x","volume":"120","author":"A Goate","year":"2012","unstructured":"Goate A, Hardy J. Twenty years of Alzheimer\u2019s disease-causing mutations. J Neurochem. 2012;120(Suppl 1):3\u20138.","journal-title":"J Neurochem"},{"issue":"4","key":"99_CR14","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","volume":"12","author":"VL Villemagne","year":"2013","unstructured":"Villemagne VL, Burnham S, Bourgeat P, Brown B, Ellis KA, Salvado O, et al. Amyloid beta deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study. Lancet Neurol. 2013;12(4):357\u201367.","journal-title":"Lancet Neurol"},{"issue":"6106","key":"99_CR15","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/325733a0","volume":"325","author":"J Kang","year":"1987","unstructured":"Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, et al. The precursor of Alzheimer\u2019s disease amyloid A4 protein resembles a cell-surface receptor. Nature. 1987;325(6106):733\u20136.","journal-title":"Nature"},{"key":"99_CR16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.3389\/fnins.2012.00081","volume":"6","author":"O Lazarov","year":"2012","unstructured":"Lazarov O, Demars MP. All in the family: how the APPs regulate neurogenesis. Front Neurosci. 2012;6:81.","journal-title":"Front Neurosci"},{"issue":"6","key":"99_CR17","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.cell.2010.08.014","volume":"142","author":"JA Duce","year":"2010","unstructured":"Duce JA, Tsatsanis A, Cater MA, James SA, Robb E, Wikhe K, et al. Iron-export ferroxidase activity of beta-amyloid precursor protein is inhibited by zinc in Alzheimer\u2019s disease. Cell. 2010;142(6):857\u201367.","journal-title":"Cell"},{"issue":"8","key":"99_CR18","doi-asserted-by":"crossref","first-page":"4075","DOI":"10.1021\/pr300123g","volume":"11","author":"BM Kohli","year":"2012","unstructured":"Kohli BM, Pflieger D, Mueller LN, Carbonetti G, Aebersold R, Nitsch RM, et al. Interactome of the amyloid precursor protein APP in brain reveals a protein network involved in synaptic vesicle turnover and a close association with Synaptotagmin-1. J Proteome Res. 2012;11(8):4075\u201390.","journal-title":"J Proteome Res"},{"issue":"35","key":"99_CR19","doi-asserted-by":"crossref","first-page":"10788","DOI":"10.1523\/JNEUROSCI.2132-09.2009","volume":"29","author":"Z Wang","year":"2009","unstructured":"Wang Z, Wang B, Yang L, Guo Q, Aithmitti N, Songyang Z, et al. Presynaptic and postsynaptic interaction of the amyloid precursor protein promotes peripheral and central synaptogenesis. J Neurosci. 2009;29(35):10788\u2013801.","journal-title":"J Neurosci"},{"issue":"2","key":"99_CR20","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrneurol.2009.218","volume":"6","author":"B Strooper De","year":"2010","unstructured":"De Strooper B, Vassar R, Golde T. The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat Rev Neurol. 2010;6(2):99\u2013107.","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"99_CR21","doi-asserted-by":"crossref","first-page":"4211","DOI":"10.1074\/jbc.M006947200","volume":"276","author":"JW Creemers","year":"2001","unstructured":"Creemers JW, Ines Dominguez D, Plets E, Serneels L, Taylor NA, Multhaup G, et al. Processing of beta-secretase by furin and other members of the proprotein convertase family. J Biol Chem. 2001;276(6):4211\u20137.","journal-title":"J Biol Chem"},{"issue":"4\u20135","key":"99_CR22","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.jmb.2012.01.006","volume":"421","author":"M Fandrich","year":"2012","unstructured":"Fandrich M. Oligomeric intermediates in amyloid formation: structure determination and mechanisms of toxicity. J Mol Biol. 2012;421(4\u20135):427\u201340.","journal-title":"J Mol Biol"},{"issue":"7409","key":"99_CR23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/nature11283","volume":"488","author":"T Jonsson","year":"2012","unstructured":"Jonsson T, Atwal JK, Steinberg S, Snaedal J, Jonsson PV, Bjornsson S, et al. A mutation in APP protects against Alzheimer\u2019s disease and age-related cognitive decline. Nature. 2012;488(7409):96\u20139.","journal-title":"Nature"},{"issue":"5","key":"99_CR24","doi-asserted-by":"crossref","first-page":"1518 e1\u20133","DOI":"10.1016\/j.neurobiolaging.2012.09.017","volume":"34","author":"M Kero","year":"2013","unstructured":"Kero M, Paetau A, Polvikoski T, Tanskanen M, Sulkava R, Jansson L, et al. Amyloid precursor protein (APP) A673T mutation in the elderly Finnish population. Neurobiol Aging. 2013;34(5):1518 e1\u20133.","journal-title":"Neurobiol Aging"},{"issue":"2","key":"99_CR25","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2174\/156720508783954758","volume":"5","author":"SL Cole","year":"2008","unstructured":"Cole SL, Vassar R. BACE1 structure and function in health and Alzheimer\u2019s disease. Curr Alzheimer Res. 2008;5(2):100\u201320.","journal-title":"Curr Alzheimer Res"},{"issue":"6761","key":"99_CR26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/990114","volume":"402","author":"S Sinha","year":"1999","unstructured":"Sinha S, Anderson JP, Barbour R, Basi GS, Caccavello R, Davis D, et al. Purification and cloning of amyloid precursor protein beta-secretase from human brain. Nature. 1999;402(6761):537\u201340.","journal-title":"Nature"},{"issue":"5440","key":"99_CR27","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1126\/science.286.5440.735","volume":"286","author":"R Vassar","year":"1999","unstructured":"Vassar R, Bennett BD, Babu-Khan S, Kahn S, Mendiaz EA, Denis P, et al. Beta-secretase cleavage of Alzheimer\u2019s amyloid precursor protein by the transmembrane aspartic protease BACE. Science. 1999;286(5440):735\u201341.","journal-title":"Science"},{"issue":"4","key":"99_CR28","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1073\/pnas.97.4.1456","volume":"97","author":"X Lin","year":"2000","unstructured":"Lin X, Koelsch G, Wu S, Downs D, Dashti A, Tang J. Human aspartic protease memapsin 2 cleaves the beta-secretase site of beta-amyloid precursor protein. Proc Natl Acad Sci USA. 2000;97(4):1456\u201360.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"99_CR29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1006\/mcne.1999.0811","volume":"14","author":"I Hussain","year":"1999","unstructured":"Hussain I, Powell D, Howlett DR, Tew DG, Meek TD, Chapman C, et al. Identification of a novel aspartic protease (Asp 2) as beta-secretase. Mol Cell Neurosci. 1999;14(6):419\u201327.","journal-title":"Mol Cell Neurosci"},{"issue":"6761","key":"99_CR30","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/990107","volume":"402","author":"R Yan","year":"1999","unstructured":"Yan R, Bienkowski MJ, Shuck ME, Miao H, Tory MC, Pauley AM, et al. Membrane-anchored aspartyl protease with Alzheimer\u2019s disease beta-secretase activity. Nature. 1999;402(6761):533\u20137.","journal-title":"Nature"},{"issue":"28","key":"99_CR31","doi-asserted-by":"crossref","first-page":"21099","DOI":"10.1074\/jbc.M002095200","volume":"275","author":"M Haniu","year":"2000","unstructured":"Haniu M, Denis P, Young Y, Mendiaz EA, Fuller J, Hui JO, et al. Characterization of Alzheimer\u2019s beta -secretase protein BACE: a pepsin family member with unusual properties. J Biol Chem. 2000;275(28):21099\u2013106.","journal-title":"J Biol Chem"},{"issue":"5489","key":"99_CR32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1126\/science.290.5489.150","volume":"290","author":"L Hong","year":"2000","unstructured":"Hong L, Koelsch G, Lin X, Wu S, Terzyan S, Ghosh AK, et al. Structure of the protease domain of memapsin 2 (beta-secretase) complexed with inhibitor. Science. 2000;290(5489):150\u20133.","journal-title":"Science"},{"issue":"37","key":"99_CR33","doi-asserted-by":"crossref","first-page":"39010","DOI":"10.1074\/jbc.M407101200","volume":"279","author":"I Qahwash","year":"2004","unstructured":"Qahwash I, He W, Tomasselli A, Kletzien RF, Yan R. Processing amyloid precursor protein at the beta-site requires proper orientation to be accessed by BACE1. J Biol Chem. 2004;279(37):39010\u20136.","journal-title":"J Biol Chem"},{"issue":"39","key":"99_CR34","doi-asserted-by":"crossref","first-page":"36788","DOI":"10.1074\/jbc.M104350200","volume":"276","author":"R Yan","year":"2001","unstructured":"Yan R, Han P, Miao H, Greengard P, Xu H. The transmembrane domain of the Alzheimer\u2019s beta-secretase (BACE1) determines its late Golgi localization and access to beta-amyloid precursor protein (APP) substrate. J Biol Chem. 2001;276(39):36788\u201396.","journal-title":"J Biol Chem"},{"issue":"43","key":"99_CR35","doi-asserted-by":"crossref","first-page":"33729","DOI":"10.1074\/jbc.M004175200","volume":"275","author":"JT Huse","year":"2000","unstructured":"Huse JT, Pijak DS, Leslie GJ, Lee VM, Doms RW. Maturation and endosomal targeting of beta-site amyloid precursor protein-cleaving enzyme. The Alzheimer\u2019s disease beta-secretase. J Biol Chem. 2000;275(43):33729\u201337.","journal-title":"J Biol Chem"},{"issue":"40","key":"99_CR36","doi-asserted-by":"crossref","first-page":"30849","DOI":"10.1074\/jbc.M003202200","volume":"275","author":"A Capell","year":"2000","unstructured":"Capell A, Steiner H, Willem M, Kaiser H, Meyer C, Walter J, et al. Maturation and pro-peptide cleavage of beta-secretase. J Biol Chem. 2000;275(40):30849\u201354.","journal-title":"J Biol Chem"},{"issue":"48","key":"99_CR37","doi-asserted-by":"crossref","first-page":"37712","DOI":"10.1074\/jbc.M005339200","volume":"275","author":"BD Bennett","year":"2000","unstructured":"Bennett BD, Denis P, Haniu M, Teplow DB, Kahn S, Louis JC, et al. A furin-like convertase mediates propeptide cleavage of BACE, the Alzheimer\u2019s beta-secretase. J Biol Chem. 2000;275(48):37712\u20137.","journal-title":"J Biol Chem"},{"issue":"14","key":"99_CR38","doi-asserted-by":"crossref","first-page":"10879","DOI":"10.1074\/jbc.M009899200","volume":"276","author":"S Benjannet","year":"2001","unstructured":"Benjannet S, Elagoz A, Wickham L, Mamarbachi M, Munzer JS, Basak A, et al. Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The pro- and transmembrane\/cytosolic domains affect its cellular activity and amyloid-beta production. J Biol Chem. 2001;276(14):10879\u201387.","journal-title":"J Biol Chem"},{"issue":"Suppl 1","key":"99_CR39","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1471-4159.2011.07512.x","volume":"120","author":"PC Kandalepas","year":"2012","unstructured":"Kandalepas PC, Vassar R. Identification and biology of beta-secretase. J Neurochem. 2012;120(Suppl 1):55\u201361.","journal-title":"J Neurochem"},{"issue":"12","key":"99_CR40","doi-asserted-by":"crossref","first-page":"11696","DOI":"10.1074\/jbc.M411296200","volume":"280","author":"X He","year":"2005","unstructured":"He X, Li F, Chang WP, Tang J. GGA proteins mediate the recycling pathway of memapsin 2 (BACE). J Biol Chem. 2005;280(12):11696\u2013703.","journal-title":"J Biol Chem"},{"issue":"1\u20133","key":"99_CR41","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0014-5793(02)03052-1","volume":"524","author":"X He","year":"2002","unstructured":"He X, Chang WP, Koelsch G, Tang J. Memapsin 2 (beta-secretase) cytosolic domain binds to the VHS domains of GGA1 and GGA2: implications on the endocytosis mechanism of memapsin 2. FEBS Lett. 2002;524(1\u20133):183\u20137.","journal-title":"FEBS Lett"},{"issue":"Pt 22","key":"99_CR42","doi-asserted-by":"crossref","first-page":"5437","DOI":"10.1242\/jcs.01422","volume":"117","author":"CA Arnim von","year":"2004","unstructured":"von Arnim CA, Tangredi MM, Peltan ID, Lee BM, Irizarry MC, Kinoshita A, et al. Demonstration of BACE (beta-secretase) phosphorylation and its interaction with GGA1 in cells by fluorescence-lifetime imaging microscopy. J Cell Sci. 2004;117(Pt 22):5437\u201345.","journal-title":"J Cell Sci"},{"issue":"6","key":"99_CR43","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1111\/j.1471-4159.2011.07623.x","volume":"120","author":"J Tan","year":"2012","unstructured":"Tan J, Evin G. Beta-site APP-cleaving enzyme 1 trafficking and Alzheimer\u2019s disease pathogenesis. J Neurochem. 2012;120(6):869\u201380.","journal-title":"J Neurochem"},{"key":"99_CR44","doi-asserted-by":"crossref","first-page":"42867","DOI":"10.1074\/jbc.M112.407072","volume":"287","author":"EL Kang","year":"2012","unstructured":"Kang EL, Biscaro B, Piazza F, Tesco G. BACE1 endocytosis and trafficking are differentially regulated by ubiquitination at lysine 501 and the di-leucine motif in the C-terminus. J Biol Chem. 2012;287:42867\u201380.","journal-title":"J Biol Chem"},{"issue":"31","key":"99_CR45","doi-asserted-by":"crossref","first-page":"24108","DOI":"10.1074\/jbc.M109.092742","volume":"285","author":"EL Kang","year":"2010","unstructured":"Kang EL, Cameron AN, Piazza F, Walker KR, Tesco G. Ubiquitin regulates GGA3-mediated degradation of BACE1. J Biol Chem. 2010;285(31):24108\u201319.","journal-title":"J Biol Chem"},{"issue":"5","key":"99_CR46","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.neuron.2007.05.012","volume":"54","author":"G Tesco","year":"2007","unstructured":"Tesco G, Koh YH, Kang EL, Cameron AN, Das S, Sena-Esteves M, et al. Depletion of GGA3 stabilizes BACE and enhances beta-secretase activity. Neuron. 2007;54(5):721\u201337.","journal-title":"Neuron"},{"issue":"1","key":"99_CR47","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.nbd.2011.03.009","volume":"43","author":"C Santosa","year":"2011","unstructured":"Santosa C, Rasche S, Barakat A, Bellingham SA, Ho M, Tan J, et al. Decreased expression of GGA3 protein in Alzheimer\u2019s disease frontal cortex and increased co-distribution of BACE with the amyloid precursor protein. Neurobiol Dis. 2011;43(1):176\u201383.","journal-title":"Neurobiol Dis"},{"issue":"38","key":"99_CR48","doi-asserted-by":"crossref","first-page":"39710","DOI":"10.1074\/jbc.M402785200","volume":"279","author":"A Schmechel","year":"2004","unstructured":"Schmechel A, Strauss M, Schlicksupp A, Pipkorn R, Haass C, Bayer TA, et al. Human BACE forms dimers and colocalizes with APP. J Biol Chem. 2004;279(38):39710\u20137.","journal-title":"J Biol Chem"},{"issue":"51","key":"99_CR49","doi-asserted-by":"crossref","first-page":"53205","DOI":"10.1074\/jbc.M410378200","volume":"279","author":"GG Westmeyer","year":"2004","unstructured":"Westmeyer GG, Willem M, Lichtenthaler SF, Lurman G, Multhaup G, Assfalg-Machleidt I, et al. Dimerization of beta-site beta-amyloid precursor protein-cleaving enzyme. J Biol Chem. 2004;279(51):53205\u201312.","journal-title":"J Biol Chem"},{"key":"99_CR50","doi-asserted-by":"crossref","first-page":"178","DOI":"10.2174\/156720512799361637","volume":"9","author":"D Fleck","year":"2012","unstructured":"Fleck D, Garratt AN, Haass C, Willem M. BACE1 dependent neuregulin proteolysis. Curr Alzheimer Res. 2012;9:178\u201383.","journal-title":"Curr Alzheimer Res"},{"issue":"6","key":"99_CR51","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1002\/ana.10208","volume":"51","author":"RM Holsinger","year":"2002","unstructured":"Holsinger RM, McLean CA, Beyreuther K, Masters CL, Evin G. Increased expression of the amyloid precursor beta-secretase in Alzheimer\u2019s disease. Ann Neurol. 2002;51(6):783\u20136.","journal-title":"Ann Neurol"},{"issue":"17","key":"99_CR52","doi-asserted-by":"crossref","first-page":"6415","DOI":"10.1073\/pnas.0710263105","volume":"105","author":"SS Hebert","year":"2008","unstructured":"Hebert SS, Horre K, Nicolai L, Papadopoulou AS, Mandemakers W, Silahtaroglu AN, et al. Loss of microRNA cluster miR-29a\/b-1 in sporadic Alzheimer\u2019s disease correlates with increased BACE1\/beta-secretase expression. Proc Natl Acad Sci USA. 2008;105(17):6415\u201320.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"99_CR53","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/archneur.59.9.1381","volume":"59","author":"H Fukumoto","year":"2002","unstructured":"Fukumoto H, Cheung BS, Hyman BT, Irizarry MC. Beta-secretase protein and activity are increased in the neocortex in Alzheimer disease. Arch Neurol. 2002;59(9):1381\u20139.","journal-title":"Arch Neurol"},{"issue":"1","key":"99_CR54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/nm0103-3","volume":"9","author":"LB Yang","year":"2003","unstructured":"Yang LB, Lindholm K, Yan R, Citron M, Xia W, Yang XL, et al. Elevated beta-secretase expression and enzymatic activity detected in sporadic Alzheimer disease. Nat Med. 2003;9(1):3\u20134.","journal-title":"Nat Med"},{"issue":"10","key":"99_CR55","doi-asserted-by":"crossref","first-page":"3632","DOI":"10.1073\/pnas.0205689101","volume":"101","author":"R Li","year":"2004","unstructured":"Li R, Lindholm K, Yang LB, Yue X, Citron M, Yan R, et al. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer\u2019s disease patients. Proc Natl Acad Sci USA. 2004;101(10):3632\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"7","key":"99_CR56","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/nm1784","volume":"14","author":"MA Faghihi","year":"2008","unstructured":"Faghihi MA, Modarresi F, Khalil AM, Wood DE, Sahagan BG, Morgan TE, et al. Expression of a noncoding RNA is elevated in Alzheimer\u2019s disease and drives rapid feed-forward regulation of beta-secretase. Nat Med. 2008;14(7):723\u201330.","journal-title":"Nat Med"},{"issue":"6","key":"99_CR57","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/ana.20144","volume":"55","author":"RM Holsinger","year":"2004","unstructured":"Holsinger RM, McLean CA, Collins SJ, Masters CL, Evin G. Increased beta-Secretase activity in cerebrospinal fluid of Alzheimer\u2019s disease subjects. Ann Neurol. 2004;55(6):898\u20139.","journal-title":"Ann Neurol"},{"issue":"6","key":"99_CR58","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1001\/archpsyc.64.6.718","volume":"64","author":"Z Zhong","year":"2007","unstructured":"Zhong Z, Ewers M, Teipel S, Burger K, Wallin A, Blennow K, et al. Levels of beta-secretase (BACE1) in cerebrospinal fluid as a predictor of risk in mild cognitive impairment. Arch Gen Psychiatry. 2007;64(6):718\u201326.","journal-title":"Arch Gen Psychiatry"},{"issue":"2","key":"99_CR59","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1002\/glia.21255","volume":"60","author":"V Velanac","year":"2012","unstructured":"Velanac V, Unterbarnscheidt T, Hinrichs W, Gummert MN, Fischer TM, Rossner MJ, et al. Bace1 processing of NRG1 type III produces a myelin-inducing signal but is not essential for the stimulation of myelination. Glia. 2012;60(2):203\u201317.","journal-title":"Glia"},{"key":"99_CR60","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3233\/JAD-2011-091153","volume":"25","author":"M Ewers","year":"2011","unstructured":"Ewers M, Cheng X, Nural HF, Walsh C, Meindl T, Teipel SJ, et al. Increased CSF- BACE1 activity associated with decreased hippocampus volume in Alzheimer\u2019s disease. J Alzheimers Dis. 2011;25:373\u201381.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"99_CR61","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1212\/01.wnl.0000229925.52203.4c","volume":"67","author":"RM Holsinger","year":"2006","unstructured":"Holsinger RM, Lee JS, Boyd A, Masters CL, Collins SJ. CSF BACE1 activity is increased in CJD and Alzheimer disease versus [corrected] other dementias. Neurology. 2006;67(4):710\u20132.","journal-title":"Neurology"},{"issue":"12","key":"99_CR62","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.clinbiochem.2008.04.022","volume":"41","author":"G Wu","year":"2008","unstructured":"Wu G, Sankaranarayanan S, Tugusheva K, Kahana J, Seabrook G, Shi XP, et al. Decrease in age-adjusted cerebrospinal fluid beta-secretase activity in Alzheimer\u2019s subjects. Clin Biochem. 2008;41(12):986\u201396.","journal-title":"Clin Biochem"},{"issue":"3","key":"99_CR63","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s12640-011-9283-6","volume":"22","author":"E Tamagno","year":"2012","unstructured":"Tamagno E, Guglielmotto M, Monteleone D, Tabaton M. Amyloid-beta production: major link between oxidative stress and BACE1. Neurotox Res. 2012;22(3):208\u201319.","journal-title":"Neurotox Res"},{"key":"99_CR64","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1750-1326-7-52","volume":"7","author":"L Chami","year":"2012","unstructured":"Chami L, Checler F. BACE1 is at the crossroad of a toxic vicious cycle involving cellular stress and beta-amyloid production in Alzheimer\u2019s disease. Mol Neurodegen. 2012;7:52.","journal-title":"Mol Neurodegen"},{"issue":"6","key":"99_CR65","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.neuron.2008.10.047","volume":"60","author":"T O\u2019Connor","year":"2008","unstructured":"O\u2019Connor T, Sadleir KR, Maus E, Velliquette RA, Zhao J, Cole SL, et al. Phosphorylation of the translation initiation factor eIF2alpha increases BACE1 levels and promotes amyloidogenesis. Neuron. 2008;60(6):988\u20131009.","journal-title":"Neuron"},{"issue":"47","key":"99_CR66","doi-asserted-by":"crossref","first-page":"10874","DOI":"10.1523\/JNEUROSCI.2350-05.2005","volume":"25","author":"RA Velliquette","year":"2005","unstructured":"Velliquette RA, O\u2019Connor T, Vassar R. Energy inhibition elevates beta-secretase levels and activity and is potentially amyloidogenic in APP transgenic mice: possible early events in Alzheimer\u2019s disease pathogenesis. J Neurosci. 2005;25(47):10874\u201383.","journal-title":"J Neurosci"},{"issue":"2","key":"99_CR67","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0002-9440(10)63159-8","volume":"164","author":"H Fukumoto","year":"2004","unstructured":"Fukumoto H, Rosene DL, Moss MB, Raju S, Hyman BT, Irizarry MC. Beta-secretase activity increases with aging in human, monkey, and mouse brain. Am J Pathol. 2004;164(2):719\u201325.","journal-title":"Am J Pathol"},{"issue":"4","key":"99_CR68","doi-asserted-by":"crossref","first-page":"e61246","DOI":"10.1371\/journal.pone.0061246","volume":"8","author":"J Tan","year":"2013","unstructured":"Tan J, Li QX, Ciccotosto G, Crouch PJ, Culvenor JG, White AR, et al. Mild oxidative stress induces redistribution of BACE1 in non-apoptotic conditions and promotes the amyloidogenic processing of Alzheimer\u2019s disease amyloid precursor protein. PLoS One. 2013;8(4):e61246.","journal-title":"PLoS One"},{"issue":"12","key":"99_CR69","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1016\/j.biocel.2010.08.017","volume":"42","author":"G Evin","year":"2010","unstructured":"Evin G, Barakat A, Masters CL. BACE: therapeutic target and potential biomarker for Alzheimer\u2019s disease. Int J Biochem Cell Biol. 2010;42(12):1923\u20136.","journal-title":"Int J Biochem Cell Biol"},{"issue":"3","key":"99_CR70","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/alzrt82","volume":"3","author":"R Vassar","year":"2011","unstructured":"Vassar R, Kandalepas PC. The beta-secretase enzyme BACE1 as a therapeutic target for Alzheimer\u2019s disease. Alzheimers Res Ther. 2011;3(3):20.","journal-title":"Alzheimers Res Ther"},{"issue":"12","key":"99_CR71","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/hmg\/10.12.1317","volume":"10","author":"SL Roberds","year":"2001","unstructured":"Roberds SL, Anderson J, Basi G, Bienkowski MJ, Branstetter DG, Chen KS, et al. BACE knockout mice are healthy despite lacking the primary beta-secretase activity in brain: implications for Alzheimer\u2019s disease therapeutics. Hum Mol Genet. 2001;10(12):1317\u201324.","journal-title":"Hum Mol Genet"},{"issue":"1","key":"99_CR72","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1460-9568.2005.04551.x","volume":"23","author":"M Ohno","year":"2006","unstructured":"Ohno M, Chang L, Tseng W, Oakley H, Citron M, Klein WL, et al. Temporal memory deficits in Alzheimer\u2019s mouse models: rescue by genetic deletion of BACE1. Eur J Neurosci. 2006;23(1):251\u201360.","journal-title":"Eur J Neurosci"},{"issue":"1","key":"99_CR73","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.nbd.2006.12.008","volume":"26","author":"M Ohno","year":"2007","unstructured":"Ohno M, Cole SL, Yasvoina M, Zhao J, Citron M, Berry R, et al. BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP\/PS1 transgenic mice. Neurobiol Dis. 2007;26(1):134\u201345.","journal-title":"Neurobiol Dis"},{"issue":"2","key":"99_CR74","doi-asserted-by":"crossref","first-page":"91","DOI":"10.2174\/157488911795933938","volume":"6","author":"G Evin","year":"2011","unstructured":"Evin G, Lessene G, Wilkins S. BACE inhibitors as potential drugs for the treatment of Alzheimer\u2019s disease: focus on bioactivity. Recent Pat CNS Drug Discov. 2011;6(2):91\u2013106.","journal-title":"Recent Pat CNS Drug Discov"},{"issue":"21","key":"99_CR75","doi-asserted-by":"crossref","first-page":"9009","DOI":"10.1021\/jm300119p","volume":"55","author":"MM Weiss","year":"2012","unstructured":"Weiss MM, Williamson T, Babu-Khan S, Bartberger MD, Brown J, Chen K, et al. Design and preparation of a potent series of hydroxyethylamine containing beta-secretase inhibitors that demonstrate robust reduction of central beta-amyloid. J Med Chem. 2012;55(21):9009\u201324.","journal-title":"J Med Chem"},{"issue":"21","key":"99_CR76","doi-asserted-by":"crossref","first-page":"9208","DOI":"10.1021\/jm300931y","volume":"55","author":"SW Gerritz","year":"2012","unstructured":"Gerritz SW, Zhai W, Shi S, Zhu S, Toyn JH, Meredith JE Jr, et al. Acyl guanidine inhibitors of beta-secretase (BACE-1): optimization of a micromolar hit to a nanomolar lead via iterative solid- and solution-phase library synthesis. J Med Chem. 2012;55(21):9208\u201323.","journal-title":"J Med Chem"},{"issue":"21","key":"99_CR77","doi-asserted-by":"crossref","first-page":"9224","DOI":"10.1021\/jm3009426","volume":"55","author":"MA Brodney","year":"2012","unstructured":"Brodney MA, Barreiro G, Ogilvie K, Hajos-Korcsok E, Murray J, Vajdos F, et al. Spirocyclic sulfamides as beta-secretase 1 (BACE-1) inhibitors for the treatment of Alzheimer\u2019s disease: utilization of structure based drug design, WaterMap, and CNS penetration studies to identify centrally efficacious inhibitors. J Med Chem. 2012;55(21):9224\u201339.","journal-title":"J Med Chem"},{"issue":"21","key":"99_CR78","doi-asserted-by":"crossref","first-page":"9346","DOI":"10.1021\/jm3009025","volume":"55","author":"BM Swahn","year":"2012","unstructured":"Swahn BM, Kolmodin K, Karlstrom S, von Berg S, Soderman P, Holenz J, et al. Design and synthesis of beta-site amyloid precursor protein cleaving enzyme (BACE1) inhibitors with in vivo brain reduction of beta-amyloid peptides. J Med Chem. 2012;55(21):9346\u201361.","journal-title":"J Med Chem"},{"issue":"10","key":"99_CR79","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1021\/jm061338s","volume":"50","author":"AK Ghosh","year":"2007","unstructured":"Ghosh AK, Kumaragurubaran N, Hong L, Kulkarni SS, Xu X, Chang W, et al. Design, synthesis, and X-ray structure of potent memapsin 2 (beta-secretase) inhibitors with isophthalamide derivatives as the P2\u2013P3-ligands. J Med Chem. 2007;50(10):2399\u2013407.","journal-title":"J Med Chem"},{"key":"99_CR80","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1471-4159.2011.07476.x","volume":"120","author":"AK Ghosh","year":"2012","unstructured":"Ghosh AK, Brindisi M, Tang J. Developing \u03b2-secretase inhibitors for treatment of Alzheimer\u2019s disease. J Neurochem. 2012;120:71\u201383.","journal-title":"J Neurochem"},{"issue":"2","key":"99_CR81","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1096\/fj.10-167213","volume":"25","author":"WP Chang","year":"2011","unstructured":"Chang WP, Huang X, Downs D, Cirrito JR, Koelsch G, Holtzman DM, et al. Beta-secretase inhibitor GRL-8234 rescues age-related cognitive decline in APP transgenic mice. FASEB J. 2011;25(2):775\u201384.","journal-title":"FASEB J"},{"issue":"46","key":"99_CR82","doi-asserted-by":"crossref","first-page":"16507","DOI":"10.1523\/JNEUROSCI.3647-11.2011","volume":"31","author":"PC May","year":"2011","unstructured":"May PC, Dean RA, Lowe SL, Martenyi F, Sheehan SM, Boggs LN, et al. Robust central reduction of amyloid-beta in humans with an orally available, non-peptidic beta-secretase inhibitor. J Neurosci. 2011;31(46):16507\u201316.","journal-title":"J Neurosci"},{"issue":"1","key":"99_CR83","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.bmcl.2011.11.024","volume":"22","author":"SJ Stachel","year":"2012","unstructured":"Stachel SJ, Steele TG, Petrocchi A, Haugabook SJ, McGaughey G, Katharine Holloway M, et al. Discovery of pyrrolidine-based beta-secretase inhibitors: lead advancement through conformational design for maintenance of ligand binding efficiency. Bioorg Medl Chem Lett. 2012;22(1):240\u20134.","journal-title":"Bioorg Medl Chem Lett"},{"issue":"3","key":"99_CR84","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/mp.2011.140","volume":"17","author":"H Treiber","year":"2012","unstructured":"Treiber H, Hagemeyer N, Ehrenreich H, Simons M. BACE1 in central nervous system myelination revisited. Mol Psychiatry. 2012;17(3):237\u20139.","journal-title":"Mol Psychiatry"},{"issue":"25","key":"99_CR85","doi-asserted-by":"crossref","first-page":"6117","DOI":"10.1021\/jm049388p","volume":"47","author":"CA Coburn","year":"2004","unstructured":"Coburn CA, Stachel SJ, Li YM, Rush DM, Steele TG, Chen-Dodson E, et al. Identification of a small molecule nonpeptide active site beta-secretase inhibitor that displays a nontraditional binding mode for aspartyl proteases. J Med Chem. 2004;47(25):6117\u20139.","journal-title":"J Med Chem"},{"issue":"1","key":"99_CR86","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.bmcl.2008.11.027","volume":"19","author":"TG Steele","year":"2009","unstructured":"Steele TG, Hills ID, Nomland AA, de Leon P, Allison T, McGaughey G, et al. Identification of a small molecule beta-secretase inhibitor that binds without catalytic aspartate engagement. Bioorg Med Chem Lett. 2009;19(1):17\u201320.","journal-title":"Bioorg Med Chem Lett"},{"issue":"21","key":"99_CR87","doi-asserted-by":"crossref","first-page":"9331","DOI":"10.1021\/jm301039c","volume":"55","author":"M Mandal","year":"2012","unstructured":"Mandal M, Zhu Z, Cumming JN, Liu X, Strickland C, Mazzola RD, et al. Design and validation of bicyclic iminopyrimidinones as beta amyloid cleaving enzyme-1 (BACE1) inhibitors: conformational constraint to favor a bioactive conformation. J Med Chem. 2012;55(21):9331\u201345.","journal-title":"J Med Chem"},{"issue":"49","key":"99_CR88","doi-asserted-by":"crossref","first-page":"41245","DOI":"10.1074\/jbc.M112.409110","volume":"287","author":"F Jeppsson","year":"2012","unstructured":"Jeppsson F, Eketjall S, Janson J, Karlstrom S, Gustavsson S, Olsson LL, et al. Discovery of AZD3839, a potent and selective BACE1 inhibitor clinical candidate for the treatment of Alzheimer disease. J Biol Chem. 2012;287(49):41245\u201357.","journal-title":"J Biol Chem"},{"issue":"21","key":"99_CR89","doi-asserted-by":"crossref","first-page":"9156","DOI":"10.1021\/jm300598e","volume":"55","author":"H Huang","year":"2012","unstructured":"Huang H, La DS, Cheng AC, Whittington DA, Patel VF, Chen K, et al. Structure- and property-based design of aminooxazoline xanthenes as selective, orally efficacious, and CNS penetrable BACE inhibitors for the treatment of Alzheimer\u2019s disease. J Med Chem. 2012;55(21):9156\u201369.","journal-title":"J Med Chem"},{"issue":"2","key":"99_CR90","doi-asserted-by":"crossref","first-page":"e31084","DOI":"10.1371\/journal.pone.0031084","volume":"7","author":"N Mattsson","year":"2012","unstructured":"Mattsson N, Rajendran L, Zetterberg H, Gustavsson M, Andreasson U, Olsson M, et al. BACE1 inhibition induces a specific cerebrospinal fluid beta-amyloid pattern that identifies drug effects in the central nervous system. PLoS One. 2012;7(2):e31084.","journal-title":"PLoS One"},{"issue":"5799","key":"99_CR91","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1126\/science.1132341","volume":"314","author":"M Willem","year":"2006","unstructured":"Willem M, Garratt AN, Novak B, Citron M, Kaufmann S, Rittger A, et al. Control of peripheral nerve myelination by the beta-secretase BACE1. Science. 2006;314(5799):664\u20136.","journal-title":"Science"},{"issue":"11","key":"99_CR92","doi-asserted-by":"crossref","first-page":"10542","DOI":"10.1074\/jbc.M310001200","volume":"279","author":"Q Li","year":"2004","unstructured":"Li Q, Sudhof TC. Cleavage of amyloid-beta precursor protein and amyloid-beta precursor-like protein by BACE 1. J Biol Chem. 2004;279(11):10542\u201350.","journal-title":"J Biol Chem"},{"issue":"18","key":"99_CR93","doi-asserted-by":"crossref","first-page":"7856","DOI":"10.1523\/JNEUROSCI.3372-12.2013","volume":"33","author":"D Fleck","year":"2013","unstructured":"Fleck D, van Bebber F, Colombo A, Galante C, Schwenk BM, Rabe L, et al. Dual cleavage of neuregulin 1 type III by BACE1 and ADAM17 liberates its EGF-like domain and allows paracrine signaling. J Neurosci. 2013;33(18):7856\u201369.","journal-title":"J Neurosci"},{"issue":"12","key":"99_CR94","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1038\/nn1797","volume":"9","author":"X Hu","year":"2006","unstructured":"Hu X, Hicks CW, He W, Wong P, Macklin WB, Trapp BD, et al. Bace1 modulates myelination in the central and peripheral nervous system. Nat Neurosci. 2006;9(12):1520\u20135.","journal-title":"Nat Neurosci"},{"issue":"6","key":"99_CR95","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrn2392","volume":"9","author":"L Mei","year":"2008","unstructured":"Mei L, Xiong WC. Neuregulin 1 in neural development, synaptic plasticity and schizophrenia. Nat Rev Neurosci. 2008;9(6):437\u201352.","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"99_CR96","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1073\/pnas.0910302107","volume":"107","author":"L Wen","year":"2009","unstructured":"Wen L, Lu Y-S, Zhu X-H, Li X-M, Woo R-S, Chen Y-J, et al. Neuregulin 1 regulates pyramidal neuron activity via ErbB4 in parvalbumin-positive interneurons. Proc Natl Acad Sci USA. 2009;107(3):1211\u20136.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"99_CR97","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/nm.2315","volume":"17","author":"GM Pitcher","year":"2011","unstructured":"Pitcher GM, Kalia LV, Ng D, Goodfellow NM, Yee KT, Lambe EK, et al. Schizophrenia susceptibility pathway neuregulin 1-ErbB4 suppresses Src upregulation of NMDA receptors. Nat Med. 2011;17(4):470\u20138.","journal-title":"Nat Med"},{"issue":"12","key":"99_CR98","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1073\/pnas.0909284107","volume":"107","author":"S Seshadri","year":"2010","unstructured":"Seshadri S, Kamiya A, Yokota Y, Prikulis I, Kano S, Hayashi-Takagi A, et al. Disrupted-in-Schizophrenia-1 expression is regulated by beta-site amyloid precursor protein cleaving enzyme-1-neuregulin cascade. Proc Natl Acad Sci USA. 2010;107(12):5622\u20137.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"14","key":"99_CR99","doi-asserted-by":"crossref","first-page":"5585","DOI":"10.1073\/pnas.0710373105","volume":"105","author":"AV Savonenko","year":"2008","unstructured":"Savonenko AV, Melnikova T, Laird FM, Stewart KA, Price DL, Wong PC. Alteration of BACE1-dependent NRG1\/ErbB4 signaling and schizophrenia-like phenotypes in BACE1-null mice. Proc Natl Acad Sci USA. 2008;105(14):5585\u201390.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"99_CR100","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1124\/jpet.107.130039","volume":"324","author":"S Sankaranarayanan","year":"2008","unstructured":"Sankaranarayanan S, Price EA, Wu G, Crouthamel MC, Shi XP, Tugusheva K, et al. In vivo beta-secretase 1 inhibition leads to brain Abeta lowering and increased alpha-secretase processing of amyloid precursor protein without effect on neuregulin-1. J Pharmacol Exp Ther. 2008;324(3):957\u201369.","journal-title":"J Pharmacol Exp Ther"},{"issue":"49","key":"99_CR101","doi-asserted-by":"crossref","first-page":"48713","DOI":"10.1074\/jbc.M303861200","volume":"278","author":"SF Lichtenthaler","year":"2003","unstructured":"Lichtenthaler SF, Dominguez DI, Westmeyer GG, Reiss K, Haass C, Saftig P, et al. The cell adhesion protein P-selectin glycoprotein ligand-1 is a substrate for the aspartyl protease BACE1. J Biol Chem. 2003;278(49):48713\u20139.","journal-title":"J Biol Chem"},{"issue":"24","key":"99_CR102","doi-asserted-by":"crossref","first-page":"23009","DOI":"10.1074\/jbc.M414648200","volume":"280","author":"HK Wong","year":"2005","unstructured":"Wong HK, Sakurai T, Oyama F, Kaneko K, Wada K, Miyazaki H, et al. Beta subunits of voltage-gated sodium channels are novel substrates of beta-site amyloid precursor protein-cleaving enzyme (BACE1) and gamma-secretase. J Biol Chem. 2005;280(24):23009\u201317.","journal-title":"J Biol Chem"},{"issue":"35","key":"99_CR103","doi-asserted-by":"crossref","first-page":"30797","DOI":"10.1074\/jbc.M505249200","volume":"280","author":"D Dominguez","year":"2005","unstructured":"Dominguez D, Tournoy J, Hartmann D, Huth T, Cryns K, Deforce S, et al. Phenotypic and biochemical analyses of BACE1- and BACE2-deficient mice. J Biol Chem. 2005;280(35):30797\u2013806.","journal-title":"J Biol Chem"},{"key":"99_CR104","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1096\/fj.12-214056","volume":"27","author":"CC Sachse","year":"2013","unstructured":"Sachse CC, Kim YH, Agsten M, Huth T, Alzheimer C, Kovacs DM, et al. BACE1 and presenilin\/gamma-secretase regulate proteolytic processing of KCNE1 and 2, auxiliary subunits of voltage-gated potassium channels. FASEB J. 2013;27:2458\u2013567.","journal-title":"FASEB J"},{"issue":"18","key":"99_CR105","doi-asserted-by":"crossref","first-page":"18146","DOI":"10.1074\/jbc.M311601200","volume":"279","author":"S Eggert","year":"2004","unstructured":"Eggert S, Paliga K, Soba P, Evin G, Masters CL, Weidemann A, et al. The proteolytic processing of the amyloid precursor protein gene family members APLP-1 and APLP-2 involves alpha-, beta-, gamma-, and epsilon-like cleavages: modulation of APLP-1 processing by n-glycosylation. J Biol Chem. 2004;279(18):18146\u201356.","journal-title":"J Biol Chem"},{"issue":"9","key":"99_CR106","doi-asserted-by":"crossref","first-page":"8589","DOI":"10.1074\/jbc.M409417200","volume":"280","author":"S Kitazume","year":"2005","unstructured":"Kitazume S, Nakagawa K, Oka R, Tachida Y, Ogawa K, Luo Y, et al. In vivo cleavage of alpha 2,6-sialyltransferase by Alzheimer beta-secretase. J Biol Chem. 2005;280(9):8589\u201395.","journal-title":"J Biol Chem"},{"issue":"18","key":"99_CR107","doi-asserted-by":"crossref","first-page":"17777","DOI":"10.1074\/jbc.M414248200","volume":"280","author":"CA Arnim von","year":"2005","unstructured":"von Arnim CA, Kinoshita A, Peltan ID, Tangredi MM, Herl L, Lee BM, et al. The low density lipoprotein receptor-related protein (LRP) is a novel beta-secretase (BACE1) substrate. J Biol Chem. 2005;280(18):17777\u201385.","journal-title":"J Biol Chem"},{"issue":"12","key":"99_CR108","doi-asserted-by":"crossref","first-page":"e8477","DOI":"10.1371\/journal.pone.0008477","volume":"4","author":"ML Hemming","year":"2009","unstructured":"Hemming ML, Elias JE, Gygi SP, Selkoe DJ. Identification of beta-secretase (BACE1) substrates using quantitative proteomics. PLoS One. 2009;4(12):e8477.","journal-title":"PLoS One"},{"issue":"14","key":"99_CR109","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1038\/emboj.2012.173","volume":"31","author":"PH Kuhn","year":"2012","unstructured":"Kuhn PH, Koroniak K, Hogl S, Colombo A, Zeitschel U, Willem M, et al. Secretome protein enrichment identifies physiological BACE1 protease substrates in neurons. EMBO J. 2012;31(14):3157\u201368.","journal-title":"EMBO J"},{"issue":"31","key":"99_CR110","doi-asserted-by":"crossref","first-page":"25927","DOI":"10.1074\/jbc.M112.377465","volume":"287","author":"L Zhou","year":"2012","unstructured":"Zhou L, Barao S, Laga M, Bockstael K, Borgers M, Gijsen H, et al. The neural cell adhesion molecules L1 and CHL1 are cleaved by BACE1 protease in vivo. J Biol Chem. 2012;287(31):25927\u201340.","journal-title":"J Biol Chem"},{"issue":"46","key":"99_CR111","doi-asserted-by":"crossref","first-page":"38408","DOI":"10.1074\/jbc.M112.415505","volume":"287","author":"B Hitt","year":"2012","unstructured":"Hitt B, Riordan SM, Kukreja L, Eimer WA, Rajapaksha TW, Vassar R. Beta-site amyloid precursor protein (APP)-cleaving enzyme 1 (BACE1)-deficient mice exhibit a close homolog of L1 (CHL1) loss-of-function phenotype involving axon guidance defects. J Biol Chem. 2012;287(46):38408\u201325.","journal-title":"J Biol Chem"},{"issue":"26","key":"99_CR112","doi-asserted-by":"crossref","first-page":"8819","DOI":"10.1523\/JNEUROSCI.1334-10.2010","volume":"30","author":"X Hu","year":"2010","unstructured":"Hu X, Zhou X, He W, Yang J, Xiong W, Wong P, et al. BACE1 deficiency causes altered neuronal activity and neurodegeneration. J Neurosci. 2010;30(26):8819\u201329.","journal-title":"J Neurosci"},{"key":"99_CR113","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1326-5-31","volume":"5","author":"BD Hitt","year":"2010","unstructured":"Hitt BD, Jaramillo TC, Chetkovich DM, Vassar R. BACE1\u2212\/\u2212 mice exhibit seizure activity that does not correlate with sodium channel level or axonal localization. Mol Neurodegener. 2010;5:31.","journal-title":"Mol Neurodegener"},{"issue":"50","key":"99_CR114","doi-asserted-by":"crossref","first-page":"11693","DOI":"10.1523\/JNEUROSCI.2766-05.2005","volume":"25","author":"FM Laird","year":"2005","unstructured":"Laird FM, Cai H, Savonenko AV, Farah MH, He K, Melnikova T, et al. BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J Neurosci. 2005;25(50):11693\u2013709.","journal-title":"J Neurosci"},{"issue":"35","key":"99_CR115","doi-asserted-by":"crossref","first-page":"8677","DOI":"10.1523\/JNEUROSCI.2440-08.2008","volume":"28","author":"H Wang","year":"2008","unstructured":"Wang H, Song L, Laird F, Wong PC, Lee HK. BACE1 knock-outs display deficits in activity-dependent potentiation of synaptic transmission at mossy fiber to CA3 synapses in the hippocampus. J Neurosci. 2008;28(35):8677\u201381.","journal-title":"J Neurosci"},{"issue":"9","key":"99_CR116","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1002\/emmm.201101084","volume":"4","author":"J Cai","year":"2012","unstructured":"Cai J, Qi X, Kociok N, Skosyrski S, Emilio A, Ruan Q, et al. \u03b2-Secretase (BACE1) inhibition causes retinal pathology by vascular dysregulation and accumulation of age pigment. EMBO Mol Med. 2012;4(9):980\u201391.","journal-title":"EMBO Mol Med"},{"issue":"16","key":"99_CR117","doi-asserted-by":"crossref","first-page":"7020","DOI":"10.1523\/JNEUROSCI.2325-12.2013","volume":"33","author":"BF Corbett","year":"2013","unstructured":"Corbett BF, Leiser SC, Ling H-P, Nagy R, Breysse N, Zhang X, et al. Sodium channel cleavage is associated with aberrant neuronal activity and cognitive deficits in a mouse model of Alzheimer\u2019s disease. J Neurosci. 2013;33(16):7020\u20136.","journal-title":"J Neurosci"},{"issue":"10","key":"99_CR118","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1371\/journal.pbio.0060257","volume":"6","author":"ML Hemming","year":"2008","unstructured":"Hemming ML, Elias JE, Gygi SP, Selkoe DJ. Proteomic profiling of gamma-secretase substrates and mapping of substrate requirements. PLoS Biol. 2008;6(10):e257.","journal-title":"PLoS Biol"},{"issue":"33","key":"99_CR119","doi-asserted-by":"crossref","first-page":"11157","DOI":"10.1523\/JNEUROSCI.2884-10.2010","volume":"30","author":"H Fukumoto","year":"2010","unstructured":"Fukumoto H, Takahashi H, Tarui N, Matsui J, Tomita T, Hirode M, et al. A noncompetitive BACE1 inhibitor TAK-070 ameliorates Abeta pathology and behavioral deficits in a mouse model of Alzheimer\u2019s disease. J Neurosci. 2010;30(33):11157\u201366.","journal-title":"J Neurosci"},{"issue":"10","key":"99_CR120","doi-asserted-by":"crossref","first-page":"8677","DOI":"10.1074\/jbc.M110.194860","volume":"286","author":"L Zhou","year":"2011","unstructured":"Zhou L, Chavez-Gutierrez L, Bockstael K, Sannerud R, Annaert W, May PC, et al. Inhibition of beta-secretase in vivo via antibody binding to unique loops (D and F) of BACE1. J Biol Chem. 2011;286(10):8677\u201387.","journal-title":"J Biol Chem"},{"issue":"84","key":"99_CR121","doi-asserted-by":"crossref","first-page":"84ra43","DOI":"10.1126\/scitranslmed.3002254","volume":"3","author":"JK Atwal","year":"2011","unstructured":"Atwal JK, Chen Y, Chiu C, Mortensen DL, Meilandt WJ, Liu Y, et al. A therapeutic antibody targeting BACE1 inhibits amyloid-beta production in vivo. Sci Transl Med. 2011;3(84):84ra43.","journal-title":"Sci Transl Med"},{"issue":"84","key":"99_CR122","doi-asserted-by":"crossref","first-page":"84ra44","DOI":"10.1126\/scitranslmed.3002230","volume":"3","author":"YJ Yu","year":"2011","unstructured":"Yu YJ, Zhang Y, Kenrick M, Hoyte K, Luk W, Lu Y, et al. Boosting brain uptake of a therapeutic antibody by reducing its affinity for a transcytosis target. Sci Transl Med. 2011;3(84):84ra44.","journal-title":"Sci Transl Med"},{"issue":"3","key":"99_CR123","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1074\/jbc.M309219200","volume":"279","author":"SC Kao","year":"2004","unstructured":"Kao SC, Krichevsky AM, Kosik KS, Tsai LH. BACE1 suppression by RNA interference in primary cortical neurons. J Biol Chem. 2004;279(3):1942\u20139.","journal-title":"J Biol Chem"},{"issue":"10","key":"99_CR124","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/nn1531","volume":"8","author":"O Singer","year":"2005","unstructured":"Singer O, Marr RA, Rockenstein E, Crews L, Coufal NG, Gage FH, et al. Targeting BACE1 with siRNAs ameliorates Alzheimer disease neuropathology in a transgenic model. Nat Neurosci. 2005;8(10):1343\u20139.","journal-title":"Nat Neurosci"},{"key":"99_CR125","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-1-60761-533-0_15","volume":"614","author":"KA Peng","year":"2010","unstructured":"Peng KA, Masliah E. Lentivirus-expressed siRNA vectors against Alzheimer disease. Methods Mol Biol. 2010;614:215\u201324.","journal-title":"Methods Mol Biol"},{"issue":"4","key":"99_CR126","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/nbt.1807","volume":"29","author":"L Alvarez-Erviti","year":"2011","unstructured":"Alvarez-Erviti L, Seow Y, Yin H, Betts C, Lakhal S, Wood MJ. Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes. Nat Biotechnol. 2011;29(4):341\u20135.","journal-title":"Nat Biotechnol"}],"container-title":["Drugs & Aging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-013-0099-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40266-013-0099-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40266-013-0099-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T08:06:45Z","timestamp":1715674005000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40266-013-0099-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7,11]]},"references-count":126,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["99"],"URL":"https:\/\/doi.org\/10.1007\/s40266-013-0099-3","relation":{},"ISSN":["1170-229X","1179-1969"],"issn-type":[{"value":"1170-229X","type":"print"},{"value":"1179-1969","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,11]]}}}